Results 31 to 40 of about 409,848 (384)
Thrombocytopenia and clinical outcomes among patients with COVID‐19 disease: A cohort study
Health Science Reports, 2023 Background and Aims Thrombocytopenia is increasingly recognized among patients with critical illness and plays a role in several diseases affecting different organ systems. Therefore, we studied the prevalence of thrombocytopenia among hospitalized COVID‐
Hussain Alkhalifa +4 more
doaj +1 more source
Thrombocytopenia in pregnancy [PDF]
Hematology, 2017 Abstract Thrombocytopenia develops in 5% to 10% of women during pregnancy or in the immediate postpartum period. A low platelet count is often an incidental feature, but it might also provide a biomarker of a coexisting systemic or gestational disorder and a potential reason for a maternal intervention or treatment that might pose harm ...
Douglas B. Cines, Lisa D. Levine
openaire +6 more sources
Risk Factors of Thrombocytopenia After Cardiac Surgery with Cardiopulmonary Bypass
Brazilian Journal of Cardiovascular Surgery, 2022 Introduction: Postoperative thrombocytopenia is common in cardiac surgery with cardiopulmonary bypass, and its risk factors are unclear. Methods: This retrospective study enrolled 3,175 adult patients undergoing valve surgeries with cardiopulmonary ...
Shujie Yan +5 more
doaj +1 more source
The Incidence, Clinical Outcomes, and Risk Factors of Thrombocytopenia in Intra-Abdominal Infection Patients: A Retrospective Cohort Study. [PDF]
PLoS ONE, 2016 Studies on the incidence and risk factors of thrombocytopenia among intra-abdominal infection patients remain absent, hindering efficacy assessments regarding thrombocytopenia prevention strategies.We retrospectively studied 267 consecutively enrolled ...
Qin Wu +9 more
doaj +1 more source
Prothrombotic immune thrombocytopenia after COVID-19 vaccination
Blood, 2021 We report five cases of prothrombotic immune thrombocytopenia after exposure to the ChAdOx1 vaccine (AZD1222, Vaxzevria) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients presented 5 to 11 days after first vaccination.
A. Tiede +11 more
semanticscholar +1 more source
Thrombocytopenia in Young Patient due to Anti Tuberculosis Drugs : A Case Report
Jurnal Respirasi, 2020 Background: Most anti-tuberculosis (ATD) drugs are relatively safe, but unusual serious reactions can occur. Thrombocytopenia is an uncommon but potentially life-threatening complication of certain ATDs and is characterized by rapid destruction of ...
Aryani Prawita Sari +1 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Thrombocytopenia is a rare but serious complication of the intravenous glycoprotein IIb/IIIa (GPIIb/IIIa; integrin αIIbβ3) receptor inhibitors (GPIs), abciximab, eptifibatide, and tirofiban. The thrombocytopenia ranges from mild (50 000–100 000 platelets/
Sem A. O. F. Rikken +4 more
doaj +1 more source
Orvosi Hetilap, 2014 Thrombocytopenia means low platelet count. This is the most frequent cause of bleeding abnormalities. Petechias, purpuras, mucosal bleeding are typical clinical findings. Severe, even life threatening gastrointestinal or intracranial bleeding may also occur. Diagnostic laboratory finding is the prolonged bleeding time.
Gadó, Klára, Domján, Gyula
openaire +3 more sources
Thrombocytopenia in Preterm Infants with Intrauterine Growth Restriction [PDF]
, 2008 Sick preterm infants often have thrombocytopenia at birth, and this is often associated with intrauterine growth restriction (IUGR), or birth weights less than the 10th percentile.
Akahori, Yo-ichiro +7 more
core +1 more source
Mechanism of thrombocytopenia in COVID-19 patients
Annals of Hematology, 2020 Since December 2019, a novel coronavirus has spread throughout China and across the world, causing a continuous increase in confirmed cases within a short period of time.
Panyang Xu, Qi Zhou, Jiancheng Xu
semanticscholar +1 more source